Skip to main content

Check out the official program to obtain detailed information about all the activities.

Full program

Monday, March 18

10:00 - 10:30 | Opening remarks - Room 112
  • Claire Match – Portfolio Director, Europe, EBD Group
  • David Thomas – SVP, Industry Research, Biotechnology Innovation Organization (BIO)
  • Miquel Rodríguez Planas – Director of Economic Development and Promotion of Barcelona City Council
  • Oriol Alcoba – Director of Industry of the Government of Catalonia


 

12:00 - 12:30 | Cluster Drinks: Aligning agendas with INNAXE and CEBR – Barcelona BioRegion of Catalonia Booth #20
  • Montse Daban - Strategic Foresight and International Relations Director BIOCAT
  • Anaïs Le Corvec - Managing Director at Council of European BioRegions (CEBR)
14:00 - 14:45 | For a greener globe: biopharma's journey towards a sustainable future - Exhibit Hall Stage
  • Jordi Ferrer - Investment Director, Ship2B Ventures
  • Mar Guell - Director, Sustainable Business, Kreab
  • Jose Maria Fernandez - Partner, Aliath Bioventures
  • Jean-Patrick Hennebelle - SVP, Head of Global Late-Stage Partnering, IPSEN
  • Joe Hopcraft - Client Partner, Biotech, IQVIA
  • Stephane Thiroloix - CEO, AlgoTx
     
15:00 - 15:45 | Rising leaders in healthcare: pioneers of creativity and innovation – Room 112
  • Lucie Ellis- Executive Director In Vivo, Citeline
  • Miquel Vila-Perelló- CEO, Splice Bio
  • Sandra Von Meier- Head of Business Development&Licensing, Debiopharm International S.A.
  • Angeli Moeller- Head of DIGI (Data and Integration Generating Insights), ROCHE
     
16:00 - 16:45 | Pharma Company Presentation: Almirall - Room 111
16:15 - 17:00 | Paving the path for groundbreaking ATMP’s - Room 111
  • Moderator: Robert Fabregat- -CEO - Biocat
  • Manel Esteller, Josep Carreras Leukaemia Research Institute
  • Lluís Pareras, Invivo Ventures
  • Alessandra Magnani, Hospital Sant Joan de Déu
  • Toni Andreu, EATRIS 

 

17:30 - 18:30 | Delegation Organizer Reception - Exhibit Hall Stage
19:00 - 21:00 | Evening Reception - MNAC

Tuesday, March 19

09:30 - 09:45 | Pharma Company Presentation – Sanofi - Room 111
  • Peter Dolan - Director of Business Development, Out-Licensing, Sanofi
09:45 - 10:30 | Therapeutic Insights. Room 111 - Neuroscience frontier: identifying opportunities of transformative therapies for neurological conditions

Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group, part of Clarivate

  • Khatereh Ahmadi - Head of Search and Evaluation Team, MSD
  • Anna Rivkin - VP, Business Development, Immunology, Cardiovascular, and Neuroscience, Bristol Myers Squibb
  • Clement Gautier - Head of External Innovation Neuroscience & Rare Disease, IPSEN
  • Tania Nadal - Clinical Development Director, Ferrer
10:00 - 10:45 | Business of Biotech. In collaboration with YVC Collective - Room 112

 In sync or offbeat: are the expectations of VCs and entrepreneurs aligned?

Moderator: Francisca Peixoto - Co-Founder, LifeLink Ventures
Moderator: Joana Correia - Analyst at Aliath Bioventures, Aliath Bioventures

  • Jack O’Meara - CEO, Ochre Bio
  • Amanda Wagner - CEO, Immunitas Therapeutics
  • Thomas Tan - Principal, Sound Bioventures
  • Valerie Vanhooren - CEO, Ona Therapeutics
11:00 - 11:45 | Business of Biotech. New generation of life science venture investing- Room 112

Moderator: Karen Chan - Associate, BioGeneration Ventures

  • Laura Lane - VP - Venture Sciences (Europe), Eli Lilly & Co
  • Clara Campas - Managing Partner and Co-Founder, Asabys
  • Jose Mesa - Partner, Columbus Venture Partners
  • Tracy Weightman - Associate Director, Intermediate Capital Group (ICG)
     
14:00 - 14:45 | Startup Stories, how it started, how it is going - Room 112
  • Montserrat Vendrell - Partner Aliath Bioventures
  • Laura Soucek - CEO Peptomyc
  • Marie Eve-Beaulieu - CSO Peptomyc
     
15:00 - 17:00 | Startup competition - Room 112
  • Stephanie Marrus - Managing Director, University of California San Francisco
  • Raul Martin - Partner, Ysios Capital
  • Hakan Goker - Managing Director, M Ventures
  • Oscar Perez - CSO, Ferrer
     
16:00 - 16:45 | Unleashing healthcare: the power of AI, data, and personalized therapies. Room 111

Moderator : Bjorn Arvidsson - Managing Director, STUNS Life science

  • Jessica Shull - Director of Digital Therapeutics, Vicore Pharma AB
  • Victor Guallar - ICREA Research Professor, Barcelona Supercomputing Center
  • Prabhu Velusami - Senior Director, Early Innovation Partnering (Retina & Data Sciences), Johnson & Johnson Innovation
  • Friedrich Von Bohlen - Co-Founder and CEO, Molecular Health GmbH
  • Amparo Cuellar - Business Development Director, BioLizard
     
16:00 - 16:30 | Talent is the new gravity: lessons from Barcelona - Exhibit hall stage
  • Koen Vandercaveye- Director of Investment Promotion, Barcelona&Partners
  • Valerie Vanhhooren- CEO Ona Therapeutics
  • Sonia Velasco- Partner, Cuatrecasas
  • Gonzalo Parra- Bioinformatics Researcher. Barcelona Supercomputing Center
  • Juan Diego Casas- Global Talent Scout, AstraZeneca
     
18:00 - 19:00 | Exhibitor Reception with Josep Sanfeliu in the piano – Barcelona BioRegion of Catalonia Booth #20
  • Josep Ll. Sanfeliu- Managing Partner, Asabys Partners

Wednesday, March 20

11:00 - 11:45 | Business development round-up “have we got a deal? - key takeaways from this week's partnering meetings”

Moderator: Mike Ward - Global Head of Thought Leadership, Decision Resources Group (Part of Clarivate)

  • Carlos Buesa - CEO, Oryzon Genomics
  • Claudia Blattner - VP and Business Development, Immatics Biotechnologies GmbH
  • Jeremy Benattar - Marketing Strategy Director, Adocia
  • Selwin Ho - CEO, Medigene
  • Patrick Meyer - Senior Director Global Strategic BD, Rentschler Biopharma SE
16:00 | Closing reception - Barcelona BioRegion of Catalonia Booth #20
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.